Argenx
ARGX
#521
Rank
A$63.87 B
Marketcap
$1,051
Share price
1.03%
Change (1 day)
80.78%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.30

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$6.68. In 2022 the company made an earnings per share (EPS) of -$21.07.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.30-70.09%
2022-$21.07